NANOBIOTIX (EPA:NANO) | WebDisclosure

Basculer en Français

11103	Companies
244258	Keywords
172360	Articles
131631	Press releases

Home
Companies
NANOBIOTIX

PRESS RELEASE

published on 03/20/2025 at 21:15, 1 year 6 months ago

NANOBIOTIX annonce la présentation de données issues de deux études de phase 1 évaluant JNJ-1900 (NBTXR3) lors du Congrès Européen sur le Cancer du Poumon
Nanobiotix annonce la présentation de données de deux études de Phase 1 évaluant JNJ-1900 (NBTXR3) lors du Congrès Européen sur le Cancer du Poumon 2025

NANOBIOTIX Cancer Du Poumon JNJ-1900 Études De Phase 1 ELCC 2025
PRESS RELEASE

published on 03/20/2025 at 21:15, 1 year 6 months ago

NANOBIOTIX Announces Presentation of Data From Two Phase 1 Studies Evaluating JNJ-1900 (NBTXR3) at the European Lung Cancer Conference
Nanobiotix announces presentation of data from two Phase 1 studies evaluating JNJ-1900 (NBTXR3) at the European Lung Cancer Conference. Studies highlight safety, efficacy, and collaboration strategies

Collaboration NANOBIOTIX Lung Cancer JNJ-1900 Phase 1 Studies
BRIEF

published on 03/17/2025 at 21:20, 1 year 6 months ago

NANOBIOTIX Prolonge son Horizon Financier jusqu'à mi-2026

Accord De Licence NANOBIOTIX NBTXR3 Visibilité Financière Janssen
BRIEF

published on 03/17/2025 at 21:20, 1 year 6 months ago

NANOBIOTIX Extends its Financial Horizon until mid-2026

License Agreement NANOBIOTIX NBTXR3 Financial Visibility Janssen
PRESS RELEASE

published on 03/17/2025 at 21:15, 1 year 6 months ago

NANOBIOTIX renforce sa visibilité financière en amendant son accord de licence globale pour JNJ-1900 (NBTXR3) qui étend son horizon de trésorerie jusqu’à mi-2026
Nanobiotix renforce sa visibilité financière en amendant son accord de licence avec JNJ-1900 (NBTXR3), étendant son horizon de trésorerie jusqu’à mi-2026. Conférence le 18/03/2025

Trésorerie Accord De Licence NANOBIOTIX Visibilité Financière JNJ-1900
PRESS RELEASE

published on 03/17/2025 at 21:15, 1 year 6 months ago

NANOBIOTIX Strengthens Financial Position Through Amendment of Global Licensing Agreement for JNJ-1900 (NBTXR3) and Extends Cash Visibility to Mid-2026
Nanobiotix strengthens financial position by amending global licensing agreement for JNJ-1900 (NBTXR3), extending cash visibility to mid-2026. Details of the amendment and future potential milestone payments outlined

Financial Position Milestone Payments NANOBIOTIX JNJ-1900 Global Licensing Agreement
BRIEF

published on 03/13/2025 at 22:20, 1 year 6 months ago

Nanobiotix Reports Voting Rights and Share Capital Details

Euronext Paris Voting Rights Financial Transparency NANOBIOTIX Shares Outstanding
BRIEF

published on 03/13/2025 at 22:20, 1 year 6 months ago

Nanobiotix publie les détails de ses droits de vote et de son capital social

Euronext Paris Droit De Vote Transparence Financière Actions En Circulation NANOBIOTIX
PRESS RELEASE

published on 03/13/2025 at 22:15, 1 year 6 months ago

Voting Rights and Shares Capital of the Company
Nanobiotix reports voting rights and shares capital. Detailed breakdown of outstanding shares and voting rights presented. Company overview and contact information included

Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
PRESS RELEASE

published on 03/13/2025 at 22:15, 1 year 6 months ago

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
Nanobiotix communique sur le nombre total d'actions et de droits de vote. Informations boursières et présentation de l'entreprise de biotechnologie

Droits De Vote Euronext Biotechnologie Actions NANOBIOTIX

Accesswire

Published on 09/30/2026 at 23:30, 1 hour 38 minutes ago

Early Warning News Release Issued with Respect to the Acquisition of Securities of Cypher Metaverse Inc.
Published on 09/30/2026 at 20:35, 4 hours 33 minutes ago

Fairplay Ventures Inc. Enters Into Definitive Agreement to Complete Qualifying Transaction With Ampere Metals Pty. Limited
Published on 09/30/2026 at 15:50, 9 hours 18 minutes ago

Innodata Opens Motion-Capture AI Lab to Help Humanoids Move Like Humans
Published on 09/30/2026 at 14:37, 10 hours 31 minutes ago

NuRAN Leverages Starlink Backhaul to Drive Higher Revenue Per Rural Site
Published on 09/30/2026 at 14:31, 10 hours 37 minutes ago

First Breach Expands Ammunition Manufacturing Operations to Seven Days a Week

View all ACCESSWIRE

EQS Group

Published on 09/30/2026 at 23:23, 1 hour 44 minutes ago

LM PAY S.A. publishes audited FY 2025 results: EBIT reaches PLN 12.4 million and exceeds preliminary result and guidance
Published on 09/30/2026 at 22:34, 2 hours 34 minutes ago

The Change of Date of the Annual Report 2025 Publication
Published on 09/30/2026 at 22:05, 3 hours 3 minutes ago

ADS-TEC Energy Reports First Half 2026 Results; Advances Gigawatt-Scale SKM Storage Project and Strengthens its Position to Scale Own & Operate Model
Published on 09/30/2026 at 22:05, 3 hours 3 minutes ago

Abivax to Present Data on Obefazimod at United European Gastroenterology (UEG) Week 2026
Published on 09/30/2026 at 22:05, 3 hours 3 minutes ago

Abivax présentera des données sur l’obéfazimod lors de l’United European Gastroenterology (UEG) Week 2026

Les Echos

Published on 09/30/2026 at 18:44, 6 hours 23 minutes ago

Broadcast of the 5th edition of “On the way up”
Published on 09/30/2026 at 18:44, 6 hours 23 minutes ago

Diffusion de la 5e édition de “On the way up”
Published on 09/30/2026 at 18:18, 6 hours 50 minutes ago

Nombre total de droits de vote et d'actions composant le capital social
Published on 09/30/2026 at 18:15, 6 hours 53 minutes ago

The Belgian State and ENGIE Group have agreed to extend the target date for concluding the Heads of Terms until 4 november 2026
Published on 09/30/2026 at 18:15, 6 hours 53 minutes ago

L’État belge et le groupe ENGIE ont convenu de reporter au 4 novembre 2026 la date cible pour la conclusion des Heads of Terms

View all LES ECHOS COMFI WIRE